Cortagen Molecular Structure & Chemistry — Research Reference
Cortagen, identified by the amino acid sequence Lysine-Glutamic acid-Aspartic acid (KED), is a well-documented short peptide bioregulator primarily investigated for its roles in neural-tissue research. Its molecular structure and precise chemical attributes are central to understanding its observed behaviors in various in vitro and in silico models.
This reference page provides a comprehensive overview of Cortagen’s detailed molecular structure, physicochemical properties, synthesis methodologies, and advanced analytical characterization techniques relevant to its research-use-only applications. The body of scientific literature surrounding peptide bioregulators, including Cortagen, is substantial, with numerous peer-reviewed publications indexed in PubMed and several registered studies on ClinicalTrials.gov underscoring the ongoing research interest in this compound class.
The Primary Structure of Cortagen: Lys-Glu-Asp (KED)
Cortagen, identified by its standard three-letter amino acid code KED, is a precisely defined tripeptide with the sequence Lysine-Glutamic Acid-Aspartic Acid. This specific primary structure underpins all its subsequent physicochemical properties and its intriguing biological activities observed in neural-tissue research. As a peptide bioregulator, its brevity is a significant characteristic, contrasting with larger protein structures and enabling potentially distinct interaction dynamics within complex biological matrices. The meticulous arrangement of these three amino acid residues is not arbitrary; each contributes uniquely to the overall chemical identity and potential functional attributes of Cortagen, influencing its charge, hydrophilicity, and conformational flexibility in solution. Understanding this fundamental building block is paramount for any rigorous investigation into Cortagen’s properties and potential research applications.
The N-terminal residue, Lysine (Lys, K), is an essential amino acid characterized by a long aliphatic side chain terminating in a primary amine group (-NH2). This ε-amino group is highly basic, possessing a pKa value typically around 10.5-10.8, meaning it is protonated and positively charged under physiological pH conditions. The presence of this positive charge is a critical determinant of Cortagen’s overall electrostatic profile and its potential interactions with negatively charged biomolecules or cellular surfaces in research models. Furthermore, the length and flexibility of the lysine side chain may allow for varied modes of interaction, including hydrogen bonding and salt bridge formation, contributing to the specificity or promiscuity of its putative binding events.
Occupying the central position is Glutamic Acid (Glu, E), an acidic amino acid. Its side chain contains a carboxylic acid group (-COOH) with a pKa value typically around 4.1-4.2. At physiological pH, this carboxyl group is deprotonated, rendering it negatively charged. The presence of this anionic moiety introduces a counter-charge to that provided by lysine, creating a localized zwitterionic character within the peptide backbone and side chains. This negative charge is crucial for balancing the overall charge of the tripeptide and plays a significant role in its solubility and potential electrostatic interactions. The amide bond connecting Lysine to Glutamic Acid, and subsequently Glutamic Acid to Aspartic Acid, forms the stable peptide backbone, which is planar and rigid due to the partial double-bond character of the C-N bond, influencing the local conformation of the peptide.
The C-terminal residue is Aspartic Acid (Asp, D), another acidic amino acid structurally similar to glutamic acid but with a shorter side chain, possessing a carboxylic acid group with a pKa value around 3.8-3.9. Like glutamic acid, its side chain carboxyl group is negatively charged at physiological pH. The combination of two negatively charged residues (Glutamic Acid and Aspartic Acid) with one positively charged residue (Lysine) at a specific arrangement within the KED sequence gives Cortagen a net charge profile that is highly dependent on pH, but generally net negative under neutral and mildly alkaline conditions when the N-terminal amine and C-terminal carboxyl groups of the peptide backbone are also considered. This precise sequence of charged and polar residues dictates its hydrophilic nature, ensuring its solubility in aqueous solutions, a prerequisite for its proposed mechanisms in neural tissue research. The C-terminal carboxyl group of aspartic acid is also deprotonated at physiological pH, adding another negative charge to the overall molecule.
Physicochemical Properties and Conformational Dynamics of the KED Tripeptide
The primary structure of Lys-Glu-Asp (KED) directly dictates its physicochemical properties, which are fundamental to understanding its behavior in experimental systems. Given its composition of one basic and two acidic amino acids, Cortagen exhibits a distinct charge profile. At physiological pH (approximately 7.4), the N-terminal amine of Lysine is protonated (positive), the side chain amine of Lysine is protonated (positive), the side chain carboxyl groups of Glutamic Acid and Aspartic Acid are deprotonated (negative), and the C-terminal carboxyl group of Aspartic Acid is deprotonated (negative). This results in a net charge that is negative, making it highly hydrophilic and readily soluble in aqueous media. The isoelectric point (pI) of KED, the pH at which the peptide carries no net electrical charge, is calculated to be acidic, typically in the range of 3.0-3.5, reflecting the dominance of acidic functional groups. This acidic pI is a crucial consideration for chromatography, electrophoresis, and solubility studies, particularly when investigating its stability or interactions under varying pH conditions within research models.
Despite being a short tripeptide, Cortagen possesses intrinsic conformational dynamics. While it is too small to adopt stable, rigid secondary structures like alpha-helices or beta-sheets that are characteristic of larger proteins, its backbone and side chains are not entirely random. The peptide bonds themselves impose planarity, restricting certain dihedral angles (phi and psi angles). However, the inherent flexibility of the C-alpha carbons and the rotational freedom of the side chains allow for a multitude of transient conformations in solution. These dynamic changes are influenced by solvent polarity, ionic strength, and temperature. For instance, the charged side chains of Lys, Glu, and Asp can form intra-molecular salt bridges or hydrogen bonds, which, though transient, can stabilize specific preferred conformations. Investigating these preferred ensembles through techniques like advanced NMR spectroscopy in solution or molecular dynamics simulations can provide insights into potential interaction motifs, even in the absence of a fixed three-dimensional structure.
The hydrophilic nature of KED is primarily due to the abundance of polar and charged functional groups on its amino acid residues. Lysine contributes a polar, positively charged side chain, while Glutamic Acid and Aspartic Acid contribute polar, negatively charged side chains. Additionally, the backbone amide and carbonyl groups are intrinsically polar, allowing for extensive hydrogen bonding with water molecules. This high degree of solvation contributes significantly to its stability in aqueous solutions, minimizing aggregation tendencies which can be problematic for longer, more hydrophobic peptides. Understanding its solubility characteristics is essential for preparing stock solutions for *in vitro* and *ex vivo* experiments, ensuring accurate and reproducible dosing in various neural tissue research models. The lack of significant hydrophobic patches also suggests that membrane permeability might be limited for the intact tripeptide, implying its interactions may predominantly occur extracellularly or via specific transporters, a hypothesis warranting further research.
The reactivity of KED is largely dictated by its functional groups. The epsilon-amine of Lysine, the alpha-amino group (N-terminus), and the carboxylic acid groups of Glutamic Acid, Aspartic Acid, and the C-terminus are all potential sites for chemical modification, should researchers wish to derivatize Cortagen for specific experimental purposes (e.g., fluorescent labeling, biotinylation). However, these groups are also susceptible to degradation pathways under harsh conditions, such as hydrolysis (of peptide bonds or side chain amides/esters if present), oxidation (though less susceptible than methionine or cysteine-containing peptides), and racemization. The relative stability of these groups under various experimental conditions must be carefully considered during handling and storage to maintain the integrity of the research material. The interplay of these physicochemical properties ultimately dictates Cortagen’s biological availability and its interaction profile within the complex milieu of neural tissue research models, making their thorough characterization indispensable for meaningful experimental design.
Chemical Synthesis and Purification Methodologies for Research-Grade Cortagen
The production of high-quality, research-grade Cortagen (Lys-Glu-Asp, KED) necessitates robust and reliable chemical synthesis and purification methodologies. Solid-Phase Peptide Synthesis (SPPS) remains the gold standard for creating peptides of this size due to its efficiency, amenability to automation, and ability to produce high purity products. The SPPS approach, pioneered by Merrifield, involves the stepwise addition of protected amino acid residues to a growing peptide chain anchored to an insoluble polymeric resin. Each amino acid is added sequentially from the C-terminus to the N-terminus, forming stable peptide bonds. Key to the success of SPPS is the use of appropriate orthogonal protecting groups for the α-amino group (typically Fmoc, 9-fluorenylmethyloxycarbonyl, for its mild cleavage conditions) and for the reactive side chain functional groups (e.g., Boc, tert-butyloxycarbonyl, or tBu, tert-butyl, ethers/esters for acidic residues like Glu and Asp, and Boc for Lysine’s ε-amine). These protecting groups prevent unwanted side reactions during coupling steps, ensuring the desired linear sequence is formed with high fidelity.
The SPPS cycle for KED typically involves several critical steps. First, the C-terminal amino acid (Asp) is anchored to a suitable resin (e.g., Wang or Rink Amide resin for C-terminal acid or amide, respectively). Then, iterative cycles of deprotection and coupling occur. The Fmoc protecting group of the N-terminus of the resin-bound amino acid is removed using a mild base (e.g., piperidine). The next Fmoc-protected amino acid (Glu) is then coupled to the free N-terminus using activating agents such as HATU (1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) or HBTU (O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate) in the presence of a base (e.g., DIPEA, N,N-diisopropylethylamine). This process is repeated for the final amino acid (Lys). After all amino acids are coupled, the completed peptide, still attached to the resin and with side chain protecting groups intact, undergoes a final cleavage step. This is usually achieved using a strong acid mixture, such as trifluoroacetic acid (TFA) with appropriate scavengers (e.g., triisopropylsilane, water, or ethanedithiol) to remove the peptide from the resin and simultaneously deprotect all side chain functional groups, yielding the crude Cortagen.
Following synthesis and cleavage, the crude Cortagen must undergo rigorous purification to achieve the high purity levels demanded for research applications. The primary purification technique is preparative Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). This method separates peptides based on their hydrophobicity, effectively removing truncated sequences, deleted peptides, and other by-products of synthesis, as well as residual scavengers and protecting group fragments. The crude peptide solution is typically injected onto a C18 stationary phase column, and a gradient elution using mobile phases of varying organic solvent concentrations (e.g., acetonitrile in water, often with a small percentage of TFA as an ion-pairing agent) is employed. Fractions containing the target peptide are collected and subsequently analyzed for purity and identity. The use of TFA, while beneficial for resolution in RP-HPLC, can also lead to the formation of TFA counter-ion salts, which may need to be exchanged for acetate or chloride if TFA’s presence might interfere with downstream research applications.
After RP-HPLC, the purified fractions of Cortagen are typically lyophilized (freeze-dried) to obtain a stable, solid powder. Lyophilization removes residual solvents and water, yielding a product that is generally more stable for long-term storage and easier to handle for experimental preparation. Crucially, every batch of research-grade Cortagen must be subjected to stringent quality control measures post-purification to confirm its identity, purity, and concentration. This includes analytical HPLC to confirm purity (typically >98% for research grade), mass spectrometry (MS) to verify molecular weight and sequence, and potentially amino acid analysis to confirm composition. Royal Peptide Labs emphasizes these rigorous steps, understanding that the integrity of the research depends on the quality of the starting materials. Our commitment to quality testing ensures that researchers receive precisely characterized and reliable peptide bioregulators.
Advanced Analytical Characterization Techniques for Cortagen (KED)
Ensuring the unequivocal identity and high purity of research-grade Cortagen (KED) is paramount for the validity and reproducibility of scientific investigations. A suite of advanced analytical techniques is routinely employed for its comprehensive characterization. Mass Spectrometry (MS) is indispensable for confirming the molecular weight and often the sequence of peptides. Electrospray Ionization Mass Spectrometry (ESI-MS) and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) are the most common methods used. ESI-MS, often coupled with liquid chromatography (LC-ESI-MS), provides highly accurate molecular mass measurements and can reveal peptide fragments through tandem MS (MS/MS), which helps confirm the amino acid sequence by identifying characteristic fragmentation patterns. MALDI-TOF MS, on the other hand, is excellent for rapid molecular weight determination and purity assessment, particularly for larger batches, providing a molecular ion peak (M+H) that precisely matches the theoretical mass of KED.
High-Performance Liquid Chromatography (HPLC) is the cornerstone for assessing the purity of synthetic peptides. Reverse-Phase HPLC (RP-HPLC) with a C18 column and a UV detector (typically at 214 nm for peptide bond absorption) is universally applied. The chromatogram reveals the presence of the main peptide peak and any impurities, which appear as separate peaks. The purity is quantified by calculating the area under the main peak as a percentage of the total peak area. For Cortagen, an analytical purity exceeding 98% is typically targeted for research applications. Beyond purity, HPLC can also be used for quantitative analysis if calibrated against known standards, determining the exact concentration of Cortagen in a solution. Chiral HPLC may also be employed to detect the presence of D-amino acid contaminants, which can arise from racemization during synthesis, ensuring the peptide consists exclusively of the biologically relevant L-amino acids.
Nuclear Magnetic Resonance (NMR) spectroscopy offers exquisite detail regarding the molecular structure and conformation of peptides in solution. For a tripeptide like KED, 1D 1H-NMR provides a fingerprint of the molecule, confirming the presence of characteristic proton signals from each amino acid residue (e.g., the distinct chemical shifts of the aliphatic protons of Lysine, the alpha and beta protons of Glutamic Acid and Aspartic Acid, and the amide protons of the peptide backbone). 2D NMR techniques, such as COSY (Correlation Spectroscopy), TOCSY (Total Correlation Spectroscopy), and NOESY (Nuclear Overhauser Effect Spectroscopy), are invaluable for complete sequence assignment and providing insights into the proximity of protons, thus informing on the local conformational preferences and dynamic behavior of Cortagen in different solvent environments. While Cortagen is too small for extensive secondary structure, NMR can still elucidate preferred dihedral angles and subtle interactions that influence its solution-state conformation.
Additional techniques further contribute to a comprehensive characterization profile. Amino Acid Analysis (AAA) provides a quantitative determination of the amino acid composition, verifying that the Lys:Glu:Asp ratio is precisely 1:1:1 after acid hydrolysis of the peptide. This serves as an independent confirmation of the overall composition, complementing sequence-specific methods. Circular Dichroism (CD) spectroscopy, while more commonly applied to larger peptides and proteins to assess secondary structure, can still provide useful information for tripeptides regarding their backbone conformation and chirality, particularly in response to changes in solvent, pH, or temperature. While KED will not exhibit strong alpha-helix or beta-sheet signals, its CD spectrum will be characteristic of its local backbone and side-chain chirality. Furthermore, elemental analysis can confirm the overall atomic composition, complementing mass spectrometry data. Our Certificate of Analysis (CoA) for Cortagen details the results from these rigorous tests, assuring researchers of the product’s quality.
Summary of Advanced Analytical Techniques for Cortagen (KED)
| Technique | Primary Application for KED | Information Provided |
|---|---|---|
| LC-MS/MS | Identity, Purity, Sequence Confirmation | Accurate molecular weight, sequence fragments, impurity detection, quantitative analysis. |
| Analytical RP-HPLC | Purity Assessment, Quantitative Analysis | Percentage purity (typically >98%), identification and quantification of impurities. |
| NMR Spectroscopy (1H, 2D) | Structural Elucidation, Conformational Dynamics | Confirmation of amino acid identity, sequence verification, solution-state conformation, side-chain interactions. |
| Amino Acid Analysis (AAA) | Compositional Verification | Quantitative determination of amino acid molar ratios (1:1:1 for Lys:Glu:Asp). |
| Circular Dichroism (CD) | Chirality and Local Conformation | Confirmation of L-amino acid configuration, insight into preferred backbone arrangements. |
Stability, Degradation Pathways, and Optimal Handling for Research Integrity
Maintaining the chemical integrity and biological activity of Cortagen (Lys-Glu-Asp, KED) is crucial for the reliability and reproducibility of neural tissue research. Peptides, by their very nature, are susceptible to various degradation pathways, and understanding these mechanisms is key to establishing optimal handling and storage protocols. The most common degradation pathway for peptides is hydrolysis, particularly of the amide bonds within the peptide backbone. This process can be catalyzed by extreme pH conditions (acid or base hydrolysis) or by enzymatic activity (peptidases). Acid hydrolysis, often encountered during improper storage or reconstitution, can lead to the scission of peptide bonds, generating smaller fragments. Basic conditions can also promote hydrolysis and, importantly, racemization of chiral centers (L- to D-amino acid conversion), which can significantly alter the peptide’s biological properties. Thus, maintaining a neutral pH environment for solutions of Cortagen is paramount, minimizing exposure to strong acids or bases.
Beyond backbone hydrolysis, specific amino acid residues within KED can also undergo degradation. While Cortagen lacks highly labile residues like methionine (prone to oxidation) or cysteine (prone to disulfide bond formation/cleavage), its aspartic acid and glutamic acid residues can be susceptible to side-chain modifications, particularly under specific conditions. For example, Asp and Glu residues can undergo rearrangement to cyclic imides (succinimide and glutarimide, respectively), particularly at elevated temperatures or in slightly acidic conditions, followed by hydrolysis to iso-peptides. This rearrangement can alter the peptide’s structure and potentially its research utility. Furthermore, the epsilon-amine of Lysine is nucleophilic and can participate in reactions such as acylation, carbamylation (with CO2), or Maillard reactions with reducing sugars, especially when exposed to elevated temperatures and moisture over extended periods. These modifications can lead to a loss of charge, altered conformation, and reduced activity.
Optimal storage conditions are critical for extending the shelf-life and ensuring the stability of Cortagen for research. Lyophilized (freeze-dried) powder is the most stable form for long-term storage, as the absence of water drastically slows down hydrolytic and other degradation reactions. Lyophilized Cortagen should be stored at ultra-low temperatures, typically -20°C or preferably -80°C, in a desiccated environment to prevent moisture absorption. Exposure to light should also be minimized, as UV radiation can induce peptide degradation, though KED is less susceptible than peptides containing aromatic residues. Prior to reconstitution, the lyophilized vial should be allowed to equilibrate to room temperature to prevent condensation, which introduces moisture. Reconstitution should be performed with sterile, high-purity solvents, typically deionized water or an appropriate buffered solution (e.g., PBS) at a neutral pH, ensuring complete dissolution without aggressive agitation that could lead to aggregation or denaturation.
Once reconstituted, Cortagen solutions are significantly more prone to degradation. Storage of reconstituted solutions should be minimized, and experiments should ideally be conducted shortly after preparation. If storage of solutions is unavoidable, they should be aliquoted into small, single-use vials to minimize freeze-thaw cycles and stored at -20°C or -80°C. Repeated freezing and thawing can induce aggregation, reduce solubility, and promote degradation. The concentration of the peptide in solution can also influence stability; highly concentrated solutions may be more prone to aggregation, while very dilute solutions might be more susceptible to surface adsorption, leading to inaccurate dosing. Researchers should always refer to specific storage and handling guidelines provided by Royal Peptide Labs, as these are developed based on extensive stability testing. Adherence to these protocols is non-negotiable for maintaining the integrity of Cortagen and, by extension, the validity of research outcomes in neural tissue models.
Molecular Basis of Putative Interactions in Neural Tissue Research Models
The molecular basis of Cortagen’s (KED) putative interactions in neural tissue research models is hypothesized to stem from its specific tripeptide sequence, which endows it with unique charge characteristics, hydrophilicity, and conformational flexibility. Unlike larger proteins that typically interact through well-defined binding pockets and extensive surface areas, short peptides like Cortagen are thought to engage in more dynamic and possibly transient interactions. The precisely positioned positively charged Lysine residue and the two negatively charged Glutamic Acid and Aspartic Acid residues create a distinct
Frequently Asked Questions
What is the exact amino acid sequence of Cortagen?
Cortagen is a tripeptide with the amino acid sequence Lysine-Glutamic acid-Aspartic acid, commonly abbreviated as KED.
How is research-grade Cortagen typically synthesized?
Research-grade Cortagen (KED) is predominantly synthesized using solid-phase peptide synthesis (SPPS), followed by cleavage from the resin, deprotection, and rigorous purification steps, typically involving High-Performance Liquid Chromatography (HPLC).
What are the primary analytical techniques used to characterize Cortagen for research?
Key analytical techniques include Mass Spectrometry (MS) for molecular weight and sequence confirmation, High-Performance Liquid Chromatography (HPLC) for purity assessment, and Nuclear Magnetic Resonance (NMR) spectroscopy for detailed structural elucidation.
What are the critical stability considerations for Cortagen in a research setting?
Cortagen’s stability is influenced by pH, temperature, enzymatic activity, and oxidative conditions. For research integrity, it is typically stored lyophilized at low temperatures (e.g., -20°C or -80°C) and reconstituted in appropriate, sterile buffers immediately before use.
Why is “research-use-only” framing important for Cortagen?
The “research-use-only” framing is crucial because Cortagen is exclusively intended for laboratory investigations and should not be used in humans or animals, nor implied for any diagnostic, therapeutic, or preventative purpose.
How does Cortagen’s short peptide structure (KED) influence its potential interactions in research models?
As a short, charged tripeptide, Cortagen’s structure (KED) presents specific side chain functionalities (basic lysine, acidic glutamate/aspartate) that can participate in electrostatic interactions, hydrogen bonding, and specific recognition events with target biomolecules in *in vitro* or *in silico* research models.
What are the major challenges in synthesizing high-purity Cortagen for research?
Challenges include ensuring complete coupling efficiency during SPPS, minimizing racemization of amino acids, achieving efficient cleavage and deprotection without side reactions, and rigorously removing impurities through chromatography to meet stringent research-grade purity standards.
Are there any specific storage guidelines for Cortagen stock solutions once reconstituted?
Reconstituted Cortagen stock solutions should generally be used promptly or aliquoted and stored frozen at -20°C or -80°C to minimize degradation, especially from enzymatic activity or oxidation. Repeated freeze-thaw cycles should be avoided.
Scientific References
All information from Royal Peptide Labs is provided for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.